Ignite Creation Date:
2024-05-05 @ 1:26 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002138
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase I Trial of Tecogalan Sodium DS-4152 Administered as an Infusion Twice Weekly for 21 Days
Sponsor:
Daiichi Pharmaceuticals
Organization:
NIH AIDS Clinical Trials Information Service